Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial - Top-Institutions - MDSpire

Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial

  • By

  • Inês Nobre

  • Marlene N. Silva

  • Sofia Franco

  • Bruno Rodrigues

  • Pedro F. Silva

  • Pedro J. Teixeira

  • Eliana V. Carraça

  • May 14, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    PAC-WOMAN trial
    PAC-WOMAN trial

    N/A, N/A

    Key Differentiators

    • Oncology

  • #2

    Early Breast Cancer Trialists’ Collaborative Group
    Early Breast Cancer Trialists’ Collaborative Group

    N/A, N/A

    Key Differentiators

    • Oncology

  • #3

    University of Florida College of Nursing
    University of Florida College of Nursing

    Gainesville, FL

    Key Differentiators

    • Nursing
    • Oncology

  • #4

    Institut Curie
    Institut Curie

    Paris, N/A

    Key Differentiators

    • Oncology

  • #5

    Swedish Cancer Institute
    Swedish Cancer Institute

    Seattle, WA

    Key Differentiators

    • Oncology

Original Source(s)

Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial

  • by Inês Nobre, Marlene N. Silva, Sofia Franco, Bruno Rodrigues, Pedro F. Silva, Pedro J. Teixeira, Eliana V. Carraça

  • May 14, 2026

Related Content

Case Report: response of HER2-positive ductal carcinoma in situ to osimertinib with supporting in vitro evidence

Glandular tissue–based versus anatomical landmark–based CTV delineation in postoperative breast cancer radiotherapy: a dosimetric comparison

Effect of lidocaine on acute pain after modified radical mastectomy: a secondary analysis of a randomized trial